HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $74,000 | -43.9% | 12,997 | -10.1% | 0.06% | -41.0% |
| Q4 2021 | $132,000 | -21.4% | 14,456 | -8.2% | 0.10% | -29.1% |
| Q3 2021 | $168,000 | -32.5% | 15,755 | -1.7% | 0.15% | -32.4% |
| Q2 2021 | $249,000 | -14.7% | 16,030 | -11.0% | 0.22% | -17.4% |
| Q1 2021 | $292,000 | -24.2% | 18,005 | -0.9% | 0.26% | -30.4% |
| Q4 2020 | $385,000 | +42.6% | 18,170 | -0.3% | 0.38% | +33.2% |
| Q3 2020 | $270,000 | +0.4% | 18,220 | -0.4% | 0.29% | -2.4% |
| Q2 2020 | $269,000 | +24.5% | 18,295 | -0.4% | 0.29% | +15.4% |
| Q1 2020 | $216,000 | -51.1% | 18,370 | -2.3% | 0.25% | -44.2% |
| Q4 2019 | $442,000 | +20.1% | 18,795 | -5.5% | 0.46% | +19.1% |
| Q3 2019 | $368,000 | -0.5% | 19,885 | 0.0% | 0.38% | +0.3% |
| Q2 2019 | $370,000 | -23.9% | 19,885 | -0.1% | 0.38% | -24.6% |
| Q1 2019 | $486,000 | – | 19,905 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |